MetaCap

Crescent Biopharma Earnings

NASDAQ: CBIOHealth CareBiotechnology: Pharmaceutical PreparationsUSD

14.91+0.79 (+5.59%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

Next earnings date

Thu, Nov 5, 2026

Fiscal period

Sep/2026

EPS estimate

$-0.72

Crescent Biopharma earnings summary

Crescent Biopharma is scheduled to report Sep/2026 earnings on Nov 5, 2026, with analysts expecting EPS of $-0.72.

Summary generated from market data by MetaCap's automated system. Methodology

Related